• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Decitabine+ CAG +DLI in relapsed acute myeloid leukemia after allogeneic stem cell transplantation.

作者信息

Wang Bianhong, Jin Xiangshu, Wang Quanshun, Jing Yu

机构信息

Medical Center, Tsinghua University, Beijing 100084, China.

出版信息

J BUON. 2016 Jan-Feb;21(1):280-1.

PMID:27061561
Abstract
摘要

相似文献

1
Decitabine+ CAG +DLI in relapsed acute myeloid leukemia after allogeneic stem cell transplantation.地西他滨 + CAG + 供者淋巴细胞输注用于异基因造血干细胞移植后复发的急性髓系白血病
J BUON. 2016 Jan-Feb;21(1):280-1.
2
D-CAG (decitabine followed by cytarabine, aclarubicin, and G-CSF) for relapsed acute myeloid leukemia after hematopoietic cell transplantation.
Ann Hematol. 2016 Jan;95(1):157-159. doi: 10.1007/s00277-015-2505-x. Epub 2015 Sep 18.
3
Successful treatment of post-transplant relapsed acute myeloid leukemia with FLT3 internal tandem duplication using the combination of induction chemotherapy, donor lymphocyte infusion, sorafenib and azacitidine. Report of three cases.采用诱导化疗、供者淋巴细胞输注、索拉非尼和阿扎胞苷联合治疗伴FLT3内部串联重复的移植后复发性急性髓系白血病。三例报告。
Einstein (Sao Paulo). 2017 Jul-Sep;15(3):355-358. doi: 10.1590/S1679-45082017RC3784. Epub 2017 Jul 24.
4
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation.维奈克拉联合阿扎胞苷和供者淋巴细胞输注治疗异基因造血干细胞移植后复发的急性髓系白血病患者。
Ann Hematol. 2022 Jan;101(1):119-130. doi: 10.1007/s00277-021-04674-x. Epub 2021 Sep 27.
5
Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT).地西他滨用于异基因造血干细胞移植（allo-SCT）后复发的急性髓系白血病（AML）患者。
Ann Hematol. 2013 Apr;92(4):549-50. doi: 10.1007/s00277-012-1607-y. Epub 2012 Oct 31.
6
Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors.在未经体外 T 细胞清除的情况下，采用半相合造血干细胞移植后改良供者淋巴细胞输注治疗复发急性白血病的化疗：与单独化疗相比具有更好的结果，并分析了预后因素。
Eur J Haematol. 2013 Oct;91(4):304-14. doi: 10.1111/ejh.12168. Epub 2013 Aug 17.
7
Donor lymphocyte infusion for the treatment of relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.供体淋巴细胞输注治疗异基因造血干细胞移植后复发的急性髓系白血病：日本造血细胞移植学会成人急性髓系白血病工作组的回顾性分析
Biol Blood Marrow Transplant. 2014 Nov;20(11):1785-90. doi: 10.1016/j.bbmt.2014.07.010. Epub 2014 Jul 14.
8
Studies of decitabine with allogeneic progenitor cell transplantation.地西他滨与异基因祖细胞移植的研究。
Leukemia. 1997 Mar;11 Suppl 1:S32-4.
9
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.减低强度预处理和异基因造血干细胞移植后复发的急性髓系白血病和骨髓增生异常综合征的治疗
Leukemia. 2007 Dec;21(12):2540-4. doi: 10.1038/sj.leu.2404828. Epub 2007 Jul 5.
10
[Clinical efficacy of decitabine plus improved CAG chemotherapy and haplo-identical donor peripheral lymphocyte infusion regimen on elderly patients with high risk myelodysplastic syndrome and acute myeloid leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):662-6. doi: 10.7534/j.issn.1009-2137.2013.03.025.

引用本文的文献

1
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors.阿扎胞苷与供体淋巴细胞输注用于急性髓系白血病及异基因造血干细胞移植后复发的骨髓增生异常综合征，供体为替代供者。
Ther Adv Hematol. 2022 Jun 17;13:20406207221090882. doi: 10.1177/20406207221090882. eCollection 2022.
2
Decitabine combined with CAG regimen in the treatment of elderly patients with acute myeloid leukemia.地西他滨联合CAG方案治疗老年急性髓系白血病患者
Pak J Med Sci. 2020 Jan-Feb;36(2):141-145. doi: 10.12669/pjms.36.2.850.
3
Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation.
用于异基因造血干细胞移植后治疗及预防复发的低甲基化药物。
Int J Hematol. 2018 Feb;107(2):138-150. doi: 10.1007/s12185-017-2364-4. Epub 2017 Nov 15.
4
Hypomethylating agents after allogeneic blood stem cell transplantation.异基因造血干细胞移植后的去甲基化药物
Stem Cell Investig. 2016 Nov 28;3:84. doi: 10.21037/sci.2016.11.04. eCollection 2016.